메뉴 바로가기 본문 바로가기

About Us

History History: BioNote Inc. is a company specializing in diagnostics which began as Anigen Inc. in 2003.

  • 2018
    2018. 04Research facility BL3 Room certified for the first time by the government
  • 2017
    2017.12Achieved sales of KRW 30 billion
    2017.11Completed construction of research facility BL2 Room / BL3 Room
    2017.04Conducted 6th capital increase with a consideration  (investment by the institutional investor)
  • 2016
    2016.09Released V-check, a fluorescence device for animals
    2016.04Conducted 5th capital increase with a consideration
    2016.03M&A with SBI / Expansion of the company
  • 2015
    2015.12Achieved sales of KRW 20 billion
    2015.11Completed construction of Dongtan Factory 2 (2-11, Seogu-dong, Hwaseong-si)
    2015.10Selected as a Promising Small & Medium Enterprise in Gyeonggi-do
    2015.05Selected as Korean Venture Entrepreneurship
    Selected as INNOBIZ Company
    2015.03Formed partnership with Samsung Electronics to sign exclusive contract for sole agency and conducted sales of PT10V
    2015.01Changed the organization from BioNote Co., Ltd. to BioNote Inc.
  • 2014
    2014.12Acquired permit and made overseas exportation for rapid diagnostic kit for detecting MERS (Middle East Respiratory Syndrome) antigen
    2014.01Acquired domestic permit for rapid diagnostic kit for E.canis / Anaplasma antibody
    Supplied single product of TB-FERON for the government’s disinfection project
    Acquired domestic permit for CaniV-4 rapid diagnostic kit
  • 2013
    2013.12Achieved sales of KRW 10 billion
    2013.03Completed construction of new office building and newly built 2 dongs in factory 1 of BioNote Co., Ltd.
  • 2012
    2012.09Passed USDA Inspection
  • 2010
    2010.12Changed the organization from BioNote Inc. to BioNote Co., Ltd.
    2010.01Incorporated into ALERE group, a diagnostic reagent company of the USA
  • 2009
    2009.12Acquired ISO 2003:13485 TUV Certification
    2009.03Moved to the Dongtan new factory (Factory 1 Seogu-dong, Hwaseong-si)
    Moved to the Dongtan new factory (Seogu-dong, Hwaseong-si)
    Changed company name from Animal Genetics Inc. to BioNote Inc.
    Acquired New Excellent Product (NEP) Certificate from the Ministry of Knowledge Economy for ELISA, the Anigen A-type Influenza antibody
  • 2008
    2008.12Completed construction of new office building in Dongtan (Seogu-dong, Hwaseong-si)
    2008.11Acquired permit for Bovine tuberculosis (TB) and Bovine Brucella ELISA
    2008.02World’s first confirmation of Canine Influenza H3N2
    2008.01Acquired permit for antigen diagnostic kit 2.0 for Canine Heartworm Disease (CHD)
  • 2007
    2007.11Changed company name from Anigen Inc. to Animal Genetics Inc.
    2007.09Developed H5 Highly Pathogenic Avian Influenza virus antigen diagnostic strip and manufacturing method
    2007.08Acquired permit for Anigen FMD NSP Antibody ELISA
    2007.05Acquired permit for Type A Influenza Antibody ELISA
  • 2006
    2006.07Conducted 4th capital increase with a consideration
    2006.04Acquired the patent for “Manufacturing Canine parvovirus antibody diagnostic kit with rapid immune chromatography”
    2006.02Conducted 3rd capital increase with a consideration
    2006.01Purchased the site for new factory in Dongtan, Hwaseong-si (3,682.6m2)
  • 2005
    2005.08Anigen Inc. moved to the new factory in Yeongtong
    2005.01Permission and market release for Porcine Epidemic Diarrhea (PED) Antigen Diagnostic Reagent Item
  • 2004
    2004.12Permit and market launch of avian influenza antigen diagnostic reagent item
    2004.09Acquired ISO 9001 certification (TUV)
    2004.07Received approval for Anigen Life Science Research Institute
    2004 07Permit and market launch of antigen diagnostic reagent items for Canine Heartworm Disease / distemper / corona / parvo
  • 2003
    2003.10Anigen factory registration (Pajang-dong, Jangan-gu, Suwon-si)
    2003.09Conducted 1st & 2nd capital increase with a consideration
    2003.03Established Anigen Inc.